{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:21:05Z","timestamp":1774282865428,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006143","name":"Department of Science and Technology","doi-asserted-by":"publisher","award":["SR\/SO\/HS-64\/2010(G)"],"award-info":[{"award-number":["SR\/SO\/HS-64\/2010(G)"]}],"id":[{"id":"10.13039\/501100006143","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIRRH","award":["NIRRH\/RA\/413\/09-2016"],"award-info":[{"award-number":["NIRRH\/RA\/413\/09-2016"]}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.gene.2018.03.083","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T02:15:17Z","timestamp":1522203317000},"page":"34-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women"],"prefix":"10.1016","volume":"661","author":[{"given":"Roshan","family":"Dadachanji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuzhat","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushree","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalini","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srabani","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2018.03.083_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12687-011-0037-1","article-title":"Frequency distribution of the single-nucleotide \u2212108C\/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease","volume":"2","author":"Ahmad","year":"2011","journal-title":"J. Commun. Genet."},{"key":"10.1016\/j.gene.2018.03.083_bb0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2337\/diabetes.51.3.841","article-title":"Factors of insulin resistance syndrome related phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans","volume":"51","author":"Arya","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.gene.2018.03.083_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.gene.2018.03.083_bb0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0412.2011.01337.x","article-title":"Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome","volume":"91","author":"Baskol","year":"2012","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.gene.2018.03.083_bb0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/09513590.2012.683068","article-title":"Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS","volume":"28","author":"Bayrak","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/09513590.2011.569607","article-title":"Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction","volume":"28","author":"Bayram","year":"2012","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0035","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ajh.2012.106","article-title":"Paraoxonase 1 (PON1) C\/T-108 association with longitudinal mean arterial blood pressure","volume":"25","author":"Bhatnagar","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.gene.2018.03.083_bb0040","first-page":"1490","article-title":"Association between paraoxonase-1 (PON-1) polymorphisms and polycystic ovary syndrome susceptibility: a meta-analysis","volume":"9","author":"Boyang Chen","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.gene.2018.03.083_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/00008571-200102000-00009","article-title":"Polymorphisms in the human paraoxonase (PON1) promoter","volume":"11","author":"Brophy","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2018.03.083_bb0050","doi-asserted-by":"crossref","DOI":"10.1086\/320600","article-title":"Effects of 5\u2032 regulatory-region polymorphisms on paraoxonase-gene (PON1) expression","volume":"68","author":"Brophy","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2018.03.083_bb0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1373\/clinchem.2006.074559","article-title":"Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay","volume":"53","author":"Browne","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.gene.2018.03.083_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biochi.2016.10.010","article-title":"Paraoxonase and atherosclerosis-related cardiovascular diseases","volume":"132","author":"Chistiakov","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.gene.2018.03.083_bb0065","first-page":"545","article-title":"Metabolic consequences of polycystic ovary syndrome","volume":"67","author":"Churchill","year":"2015","journal-title":"Minerva Ginecol."},{"key":"10.1016\/j.gene.2018.03.083_bb0070","first-page":"387","article-title":"Paraoxonase 1 genotype-phenotype correlation in patients with metabolic syndrome","volume":"56","author":"Ciumarnean","year":"2015","journal-title":"Romanian J. Morphol. Embryol."},{"key":"10.1016\/j.gene.2018.03.083_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2015.03.037","article-title":"PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome","volume":"104","author":"Dadachanji","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gene.2018.03.083_bb0080","article-title":"Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position-107, implicating the Sp1 transcription factor","volume":"372","author":"Deakin","year":"2003","journal-title":"Biochem Jl."},{"key":"10.1016\/j.gene.2018.03.083_bb0085","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/cbf.1607","article-title":"Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population","volume":"27","author":"Demirdogen","year":"2009","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.gene.2018.03.083_bb0090","first-page":"694","article-title":"Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7","volume":"59","author":"Duggirala","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2018.03.083_bb0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/humrep\/dei284","article-title":"Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS?","volume":"21","author":"Dursun","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gene.2018.03.083_bb0100","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/oby.2012.74","article-title":"Metabolic syndrome is linked to chromosome 7q21 and associated with genetic variants in CD36 and GNAT3 in Mexican Americans","volume":"20","author":"Farook","year":"2012","journal-title":"Obesity (Silver Spring, Md)."},{"key":"10.1016\/j.gene.2018.03.083_bb0105","first-page":"879","article-title":"Paraoxonase levels in women with polycystic ovary syndrome","volume":"52","author":"Fenkci","year":"2007","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.gene.2018.03.083_bb0110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3892\/br.2013.214","article-title":"Association of \u2212108 C>T polymorphism with polycystic ovary syndrome","volume":"2","author":"Ferk","year":"2014","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.gene.2018.03.083_bb0115","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1194\/jlr.D600045-JLR200","article-title":"The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity","volume":"48","author":"Gaidukov","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.gene.2018.03.083_bb0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.2005-1696","article-title":"Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome","volume":"91","author":"Gonzalez","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2018.03.083_bb0125","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1210\/jc.2012-1259","article-title":"Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women","volume":"97","author":"Gonzalez","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2018.03.083_bb0130","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2008-0403","article-title":"Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome","volume":"93","author":"Goodarzi","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2018.03.083_bb0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2009.09.025","article-title":"Paraoxonase: a multifaceted biomolecule","volume":"410","author":"Goswami","year":"2009","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.gene.2018.03.083_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Group","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gene.2018.03.083_bb0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2298\/SARH1310629G","article-title":"Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis","volume":"141","author":"Grubisa","year":"2013","journal-title":"Srp. Arh. Celok. Lek."},{"key":"10.1016\/j.gene.2018.03.083_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017805","article-title":"Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis","volume":"6","author":"Gupta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.03.083_bb0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.gene.2011.07.011","article-title":"Serum paraoxonase-1 (PON1) activities (PONase\/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population","volume":"487","author":"Gupta","year":"2011","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.03.083_bb0165","article-title":"Association between PON 1 polymorphisms, PON activity and diabetes complications","volume":"20","author":"Hofer","year":"2006","journal-title":"J. Diabetes Complicats"},{"key":"10.1016\/j.gene.2018.03.083_bb0170","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the NIH 1990 criteria","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gene.2018.03.083_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-8227(02)00280-2","article-title":"Relationships between polymorphisms of the human serum paraoxonase gene and insulin sensitivity in Japanese patients with type 2 diabetes","volume":"60","author":"Ikeda","year":"2003","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.gene.2018.03.083_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.fertnstert.2016.04.040","article-title":"Genetic determinants of polycystic ovary syndrome: progress and future directions","volume":"106","author":"Jones","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gene.2018.03.083_bb0185","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1055\/s-0029-1222564","article-title":"Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome","volume":"134","author":"Knebel","year":"2009","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.gene.2018.03.083_bb0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/09513590.2014.887063","article-title":"The effects of metformin on endothelial dysfunction, lipid metabolism and oxidative stress in women with polycystic ovary syndrome","volume":"30","author":"Kocer","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0195","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11033-011-0819-x","article-title":"Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome","volume":"39","author":"Kordi-Tamandani","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2018.03.083_bb0200","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.atherosclerosis.2011.07.119","article-title":"The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates beta-cell insulin release","volume":"219","author":"Koren-Gluzer","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2018.03.083_bb0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2013.03.028","article-title":"Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1\/Akt pathway","volume":"229","author":"Koren-Gluzer","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2018.03.083_bb0210","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1353\/hub.2005.0040","article-title":"Bivariate linkage analysis of the insulin resistance syndrome phenotypes on chromosome 7q","volume":"77","author":"Lehman","year":"2005","journal-title":"Hum. Biol."},{"key":"10.1016\/j.gene.2018.03.083_bb0215","doi-asserted-by":"crossref","DOI":"10.1161\/01.ATV.20.2.516","article-title":"Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations","volume":"20","author":"Leviev","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.gene.2018.03.083_bb0220","first-page":"7088","article-title":"Risk association of polycystic ovary syndrome with paraoxonase 1 and TNF-\u03b1 gene polymorphisms: a meta-analysis","volume":"9","author":"Liu Liu","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.gene.2018.03.083_bb0225","article-title":"Androgen excess produces systemic oxidative stress and predisposes to beta-cell failure in female mice","volume":"5","author":"Liu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2018.03.083_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5114\/aoms.2013.33189","article-title":"Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease","volume":"9","author":"Mackness","year":"2013","journal-title":"Arch. Med. Sci. AMS"},{"key":"10.1016\/j.gene.2018.03.083_bb0235","first-page":"75","article-title":"Relation between paraoxonase 1 (PON1) gene polymorphism & insulin resistance in polycystic ovary syndrome (PCOS)","volume":"1","author":"Manal Abu Farha","year":"2010","journal-title":"Kasr Al-Aini J. Obstet. Gynecol."},{"key":"10.1016\/j.gene.2018.03.083_bb0240","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Miryam","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2018.03.083_bb0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pathophys.2009.11.004","article-title":"Serum paraoxonase 1 activity and oxidant\/antioxidant status in Saudi women with polycystic ovary syndrome","volume":"17","author":"Mohamadin","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.gene.2018.03.083_bb0250","first-page":"3346","article-title":"Effect of paraoxonase gene polymorphisms on paraoxonase levels and insulin resistance index in women with polcystic ovary syndrome","volume":"3","author":"Mohamed","year":"2009","journal-title":"Aust. J. Basic Appl. Sci."},{"key":"10.1016\/j.gene.2018.03.083_bb0255","first-page":"197","article-title":"Benefits of omega-3 fatty acids supplementation on serum paraoxonase 1 activity and lipids ratios in polycystic ovary syndrome","volume":"2","author":"Mohammadi","year":"2012","journal-title":"Health Promot. Perspect."},{"key":"10.1016\/j.gene.2018.03.083_bb0260","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/humupd\/dms059","article-title":"Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis","volume":"19","author":"Murri","year":"2013","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.gene.2018.03.083_bb0265","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cen.12139","article-title":"PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia","volume":"79","author":"Paltoglou","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0270","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s00421-002-0668-3","article-title":"\u201cOxidative stress\u201d: effects of mild endurance training and testosterone treatment on rat gastrocnemius muscle","volume":"87","author":"Pansarasa","year":"2002","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.gene.2018.03.083_bb0275","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.clinbiochem.2004.10.005","article-title":"Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia","volume":"38","author":"Roest","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.gene.2018.03.083_bb0280","doi-asserted-by":"crossref","first-page":"22376","DOI":"10.1074\/jbc.271.37.22376","article-title":"Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human","volume":"271","author":"Rowles","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.gene.2018.03.083_bb0285","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2003-031252","article-title":"Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity","volume":"89","author":"San Millan","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2018.03.083_bb0290","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1093\/humrep\/del300","article-title":"The PON1-108C\/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women","volume":"21","author":"San Millan","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.gene.2018.03.083_bb0295","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10815-013-0025-y","article-title":"Peroxisome proliferator activated receptor gamma gene variants influence susceptibility and insulin related traits in Indian women with polycystic ovary syndrome","volume":"30","author":"Shaikh","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.gene.2018.03.083_bb0300","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.gene.2015.11.033","article-title":"Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women","volume":"577","author":"Shaikh","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.03.083_bb0305","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/ars.2010.3774","article-title":"The human paraoxonase gene cluster as a target in the treatment of atherosclerosis","volume":"16","author":"She","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.gene.2018.03.083_bb0310","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.fertnstert.2010.12.011","article-title":"Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome","volume":"95","author":"Soyman","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.gene.2018.03.083_bb0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0021-9150(99)00379-2","article-title":"A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression","volume":"150","author":"Suehiro","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.gene.2018.03.083_bb0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.gene.2018.03.083_bb0325","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3109\/09513590.2011.569798","article-title":"Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered","volume":"27","author":"Torun","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0330","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.gene.2018.03.083_bb0335","first-page":"277","article-title":"Associations of single nucleotide polymorphisms related to insulin resistance with polycystic ovary syndrome","volume":"44","author":"Woo","year":"2014","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.gene.2018.03.083_bb0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12958-016-0203-8","article-title":"Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis","volume":"14","author":"Yang","year":"2016","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0345","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1158\/0008-5472.CAN-04-1651","article-title":"CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer","volume":"64","author":"Zeigler-Johnson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2018.03.083_bb0350","first-page":"24","article-title":"The \u2212108 C\/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome","volume":"42","author":"Zhang","year":"2011","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"key":"10.1016\/j.gene.2018.03.083_bb0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2350-14-16","article-title":"Association between paraoxonase gene and stroke in the Han Chinese population","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.gene.2018.03.083_bb0360","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/EJE-14-0863","article-title":"Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome","volume":"172","author":"Zhang","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.gene.2018.03.083_bb0365","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/cen.13171","article-title":"Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome","volume":"86","author":"Zhang","year":"2016","journal-title":"Clin. Endocrinol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918303330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918303330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T22:42:11Z","timestamp":1565304131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918303330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":73,"alternative-id":["S0378111918303330"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.03.083","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PON1 promoter polymorphisms contribute to PCOS susceptibility and phenotypic outcomes in Indian women","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.03.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}